Connor, Clark & Lunn Investment Management Ltd. - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q2 2023$151,480
-54.7%
126,233
-52.5%
0.00%
-50.0%
Q1 2023$334,711
-77.0%
265,644
+118.6%
0.00%
-80.0%
Q3 2022$1,456,000
+203.3%
121,546
+111.9%
0.01%
+233.3%
Q2 2022$480,000
+22.1%
57,367
+26.8%
0.00%
+50.0%
Q1 2022$393,000
-24.0%
45,254
-1.0%
0.00%
-33.3%
Q4 2021$517,000
-11.6%
45,719
-1.7%
0.00%0.0%
Q3 2021$585,00046,5060.00%
Other shareholders
GOSSAMER BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,320,608$41,209,00011.15%
Boxer Capital, LLC 2,562,358$31,799,0001.10%
Integral Health Asset Management, LLC 200,000$2,482,0000.76%
Palo Alto Investors LP 1,077,200$13,368,0000.73%
Artal Group S.A. 2,358,968$29,275,0000.71%
HHLR ADVISORS, LTD. 7,420,974$92,094,0000.70%
MASTERS CAPITAL MANAGEMENT LLC 700,000$8,687,0000.58%
Ikarian Capital, LLC 582,494$7,229,0000.52%
CLOUGH CAPITAL PARTNERS L P 459,834$5,707,0000.41%
Alyeska Investment Group, L.P. 1,173,301$14,561,0000.22%
View complete list of GOSSAMER BIO INC shareholders